Newsroom

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Buffer UCITS ETF - July 17.03.2026 FJUL.LN IE000YJBT6I5 100,002.00 USD 2,668,186.98 26.681  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Buffer UCITS ETF - April 17.03.2026 FAPR.LN IE000WX2HZQ7 150,002.00 USD 3,693,959.84 24.626  ...

TEL AVIV, Israel--(BUSINESS WIRE)--ICL (NYSE: ICL) (TASE: ICL), a leading global specialty minerals company, today announced the opening of a new specialty fertilizer production facility in Maharashtra, India. The launch comes at a critical time for India, which relies heavily on fertilizer imports and is now facing supply disruptions due to the latest geopolitical instability and the closure of the Strait of Hormuz - a key global shipping corridor. These delays are already affecting fertilizer...

TULSA, Okla.--(BUSINESS WIRE)--Empire Petroleum Corporation (NYSE American: EP) ("Empire" or the "Company"), an oil and gas company with current producing assets in New Mexico, North Dakota, Montana, Texas, and Louisiana, today announced it has elected to participate in a new oil and natural gas development program in Louisiana that represents a meaningful addition to the Company’s ongoing development activities. Empire has completed its due diligence and elected to participate in a three-well...

NEW YORK--(BUSINESS WIRE)--  18th March 2026 CRH plc Transaction in Own Shares CRH plc (“CRH”) announces that on 17th March 2026 it acquired the following number of its ordinary shares (the “ordinary shares”) in the United States through CRH’s broker Wells Fargo Securities, LLC. The ordinary shares acquired (by way of redemption) will be cancelled. Aggregate number of ordinary shares acquired Daily volume weighted average price paid Daily highest price paid per share Daily lowest price per shar...

PARIS--(BUSINESS WIRE)--Regulatory News: NE PAS DISTRIBUER, DIRECTEMENT OU INDIRECTEMENT, AUX ÉTATS-UNIS D’AMÉRIQUE, AU CANADA, EN AUSTRALIE, AU JAPON ET EN AFRIQUE DU SUD GenSight Biologics (la « Société ») (Euronext : SIGHT, ISIN : FR0013183985, éligible PEA-PME), une société biopharmaceutique spécialisée dans le développement et la commercialisation de thérapies géniques innovantes pour les maladies neurodégénératives de la rétine et les troubles du système nerveux central, annonce le règlem...

PARIS--(BUSINESS WIRE)--Regulatory News: NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA, JAPAN AND SOUTH AFRICA GenSight Biologics (the "Company") (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and central nervous system disorders, today announced the closing of its EUR 1,694,715.5256 fundraising (the "Fundrais...

MEUDON, Francia--(BUSINESS WIRE)--L’elaborazione quantistica ha il potenziale per violare, prima o poi, gli attuali metodi di crittografia, mettendo a rischio le comunicazioni mobili, i dati personali e le infrastrutture cruciali. Il testo originale del presente annuncio, redatto nella lingua di partenza, è la versione ufficiale che fa fede. Le traduzioni sono offerte unicamente per comodità del lettore e devono rinviare al testo in lingua originale, che è l'unico giuridicamente valido....

MEUDON, Frankreich--(BUSINESS WIRE)--Laut dem Thales Data Threat Report 2026 betrachten Unternehmen aus 20 Märkten und 17 Branchen die rasante Entwicklung der KI-gestützten Transformation als ihre aktuell größte Herausforderung im Bereich der Sicherheit. Basierend auf den Ergebnissen der von S&P Global Market Intelligence 451 Research erhobenen Daten bezeichnen 61 Prozent der Befragten die KI als ihr stärkstes Risiko für die Datensicherheit. Sorgen bereiten nicht nur Bedrohungen durch bösar...

SAN DIEGO--(BUSINESS WIRE)--Researchers at Inocras, a bioinformatics-led precision health company harnessing the power of whole-genome sequencing (WGS) data and proprietary analytics, and the Broad Institute jointly announced the upcoming release of key insights from whole-genome analysis of over 8,000 public cancer whole genomes. This analysis aims to deliver one of the largest genome-wide landscapes of somatic mutations across human pan-cancers. “NCI’s public The Cancer Genome Atlas (TCGA) ef...